Genzyme to invest $100m expanding Belgian facility

02 April 2002 21:25  [Source: ICIS news]

HOUSTON (CNI)--US biotechnology company Genzyme Corporation will invest more than $100m (Euro115m) to expand its recently acquired facility in Geel, Belgium and transform it into a world-class protein production operation by 2004, the company told CNI Tuesday.

Genzyme acquired the complex last year from the Dutch biotechnology and pharmaceutical company Pharming, buying all of Pharming's Belgian assets.

A subsidiary of Cincinnati, Ohio-based Jacobs Engineering Group will provide full service design, engineering, procurement and construction management services at the Geel location. Groundbreaking on the project is set for the third quarter.

Genzyme is headquartered in Cambridge, Massachusetts.

By: Gary Taylor
+1 713 525 2653

< previous article(ICIS Podcast: Chemical News Central 2 November 2009)

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly